{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:04:08Z","timestamp":1781129048830,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary hepatic neuroendocrine tumors (PH-NETs) are extremely rare and unknown. Because of its rarity, its prognosis features and influencing factors are not well established.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data of 140 patients with PH-NETs diagnosed in the SEER database from 1975 to 2016 were collected. The demographics and clinic-pathological features were described. By using propensity-score matching (PSM) analysis, three associated cohorts were selected to describe the malignancy of PH-NETs and univariate analysis was conducted. Then, multivariate Cox analyses were performed and a predicting nomograph was constructed. C-index, receiver operating characteristic (ROC) curve and calibration curves were used to evaluate the predictive value of nomogram.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The overall survival outcomes of PH-NETs were superior to hepatocellular carcinoma (HCC) with a mean survival time 30.64 vs 25.11\u2009months (<jats:italic>p<\/jats:italic>\u2009=\u20090.052), but inferior to gastrointestinal tract neuroendocrine tumors in situ (GI-NETs in situ) with a mean survival time 30.64 vs 41.62\u2009months (<jats:italic>p<\/jats:italic>\u2009=\u20090.017). With reference to gastrointestinal neuroendocrine tumors with liver metastasis (GI-NETs-LM), GI-NETs-LM had better outcomes in short time (1-year survival rate: 64.75% vs 56.43%) but was worse in long time (5-year survival rate: 8. 63% vs 18.57%). Multivariate Cox analyses showed that tumor grade and surgery were two independent factors for prognosis of the patients (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00). Tumor grade and surgery were used to construct the predicting nomogram. The C-index was 0.79 (95%CI\u2009=\u20090.75\u20130.83). The area under curve (AUC) values in ROC were 0.868 in 1-year and 0.917 in 3-year survival and the calibration curves showed good consistency.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The overall prognosis PH-NETs is generally favorable, better than HCC and GI-NETs-LM in long term. Preoperative biopsy and complete pathological diagnosis were recommended. Radical surgical intervention including transplantation was the first choice in PH-NETs therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08337-y","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T04:16:31Z","timestamp":1621311391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database"],"prefix":"10.1186","volume":"21","author":[{"given":"Ziteng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youchun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"issue":"18","key":"8337_CR1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063\u201372. https:\/\/doi.org\/10.1200\/JCO.2007.15.4377.","journal-title":"J Clin Oncol"},{"issue":"10","key":"8337_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335\u201342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589.","journal-title":"JAMA Oncol"},{"key":"8337_CR3","volume-title":"Tumors of the liver and intrahepatic bile ducts, vol. 25: Armed Forces Institute of Pathology","author":"HA Edmondson","year":"1958","unstructured":"Edmondson HA. Tumors of the liver and intrahepatic bile ducts, vol. 25: Armed Forces Institute of Pathology; 1958."},{"issue":"4","key":"8337_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934\u201359. https:\/\/doi.org\/10.1002\/cncr.11105.","journal-title":"Cancer"},{"issue":"6","key":"8337_CR5","doi-asserted-by":"publisher","first-page":"751","DOI":"10.4067\/S0034-98872019000600751","volume":"147","author":"G Araneda","year":"2019","unstructured":"Araneda G, Poniachik R, Freundlich A, Carre\u00f1o L, Poniachik J. Primary malignant hepatic tumors other than hepatocarcinoma or cholangiocarcinoma. A series of cases. Revista medica de Chile. 2019;147(6):751\u20134. https:\/\/doi.org\/10.4067\/S0034-98872019000600751.","journal-title":"Revista medica de Chile"},{"issue":"9","key":"8337_CR6","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S0046-8177(84)80152-5","volume":"15","author":"SH Barsky","year":"1984","unstructured":"Barsky SH, Linnoila I, Triche TJ, Costa J. Hepatocellular carcinoma with carcinoid features. Hum Pathol. 1984;15(9):892\u20134. https:\/\/doi.org\/10.1016\/S0046-8177(84)80152-5.","journal-title":"Hum Pathol"},{"issue":"10","key":"8337_CR7","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.3748\/wjg.v21.i10.3132","volume":"21","author":"K Yang","year":"2015","unstructured":"Yang K, Cheng Y-S, Yang J-J, Jiang X, Guo J-X. Primary hepatic neuroendocrine tumor with multiple liver metastases: a case report with review of the literature. World J Gastroenterol. 2015;21(10):3132\u20138. https:\/\/doi.org\/10.3748\/wjg.v21.i10.3132.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"8337_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0046-8177(74)80041-9","volume":"5","author":"LI Alpert","year":"1974","unstructured":"Alpert LI, Zak FG, Werthamer S, Bochetto JF. Cholangiocarcinoma: a clinicopathologic study of five cases with ultrastructural observations. Hum Pathol. 1974;5(6):709\u201328. https:\/\/doi.org\/10.1016\/S0046-8177(74)80041-9.","journal-title":"Hum Pathol"},{"issue":"8","key":"8337_CR9","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1002\/1097-0142(19930415)71:8<2660::AID-CNCR2820710835>3.0.CO;2-4","volume":"71","author":"C Hsueh","year":"1993","unstructured":"Hsueh C, Tan XD, Gonzalez-Crussi F. Primary hepatic neuroendocrine carcinoma in a child. Morphologic, immunocytochemical, and molecular biologic studies. Cancer. 1993;71(8):2660\u20135. https:\/\/doi.org\/10.1002\/1097-0142(19930415)71:8<2660::AID-CNCR2820710835>3.0.CO;2-4.","journal-title":"Cancer"},{"issue":"10","key":"8337_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1245\/ASO.2003.04.533","volume":"10","author":"CD Knox","year":"2003","unstructured":"Knox CD, Anderson CD, Lamps LW, Adkins RB, Pinson CW. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol. 2003;10(10):1171\u20135. https:\/\/doi.org\/10.1245\/ASO.2003.04.533.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"8337_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1196\/annals.1294.027","volume":"1014","author":"A Sundin","year":"2004","unstructured":"Sundin A, Eriksson B, Bergstr\u00f6m M, L\u00e5ngstr\u00f6m B, Oberg K, Orlefors H. PET in the diagnosis of neuroendocrine tumors. Ann N Y Acad Sci. 2004;1014(1):246\u201357. https:\/\/doi.org\/10.1196\/annals.1294.027.","journal-title":"Ann N Y Acad Sci"},{"key":"8337_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.humpath.2019.12.002","volume":"96","author":"AM Bellizzi","year":"2020","unstructured":"Bellizzi AM. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? Hum Pathol. 2020;96:8\u201333. https:\/\/doi.org\/10.1016\/j.humpath.2019.12.002.","journal-title":"Hum Pathol"},{"issue":"2","key":"8337_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/01.sla.0000109155.89514.42","volume":"239","author":"SW Fenwick","year":"2004","unstructured":"Fenwick SW, Wyatt JI, Toogood GJ, Lodge JP. Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg. 2004;239(2):210\u20139. https:\/\/doi.org\/10.1097\/01.sla.0000109155.89514.42.","journal-title":"Ann Surg"},{"issue":"4","key":"8337_CR14","first-page":"746","volume":"7","author":"M Iwao","year":"2001","unstructured":"Iwao M, Nakamuta M, Enjoji M, Kubo H, Fukutomi T, Tanabe Y, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monitor. 2001;7(4):746\u201350.","journal-title":"Med Sci Monitor"},{"issue":"8","key":"8337_CR15","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/j.1440-1746.2012.07117.x","volume":"27","author":"CH Park","year":"2012","unstructured":"Park CH, Chung JW, Jang SJ, Chung MJ, Bang S, Park SW, et al. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas. J Gastroenterol Hepatol. 2012;27(8):1306\u201311. https:\/\/doi.org\/10.1111\/j.1440-1746.2012.07117.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"8337_CR16","doi-asserted-by":"publisher","first-page":"e3144","DOI":"10.17795\/ijcp-3144","volume":"8","author":"SR Mousavi","year":"2015","unstructured":"Mousavi SR, Ahadi M. Primary neuroendocrine tumor of liver (rare tumor of liver). Iranian journal of cancer prevention. 2015;8(6):e3144.","journal-title":"Iranian journal of cancer prevention"},{"issue":"3","key":"8337_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4318\/tjg.2012.0465","volume":"23","author":"O Yalav","year":"2012","unstructured":"Yalav O, \u00dclk\u00fc A, Ak\u00e7am TA, Demiry\u00fcrek H, Doran F. Primary hepatic neuroendocrine tumor: five cases with different preoperative diagnoses. Turkish J Gastroenterol. 2012;23(3):272\u20138. https:\/\/doi.org\/10.4318\/tjg.2012.0465.","journal-title":"Turkish J Gastroenterol"},{"issue":"1","key":"8337_CR18","first-page":"44","volume":"9","author":"YQ Huang","year":"2010","unstructured":"Huang YQ, Xu F, Yang JM, Huang B. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases. Hepatobiliary Pancreatic Dis Int. 2010;9(1):44\u20138.","journal-title":"Hepatobiliary Pancreatic Dis Int"},{"issue":"1","key":"8337_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1477-7819-6-91","volume":"6","author":"G Schwartz","year":"2008","unstructured":"Schwartz G, Colanta A, Gaetz H, Olichney J, Attiyeh F. Primary carcinoid tumors of the liver. World J Surgical Oncol. 2008;6(1):91. https:\/\/doi.org\/10.1186\/1477-7819-6-91.","journal-title":"World J Surgical Oncol"},{"issue":"1","key":"8337_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/13651820310017228","volume":"6","author":"M Nikfarjam","year":"2004","unstructured":"Nikfarjam M, Muralidharan V, Christophi C. Primary hepatic carcinoid tumours. HPB. 2004;6(1):13\u20137. https:\/\/doi.org\/10.1080\/13651820310017228.","journal-title":"HPB"},{"issue":"12","key":"8337_CR21","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1097\/PAS.0000000000000749","volume":"40","author":"MA Duggan","year":"2016","unstructured":"Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME. The surveillance, epidemiology, and end results (SEER) program and pathology: toward strengthening the critical relationship. Am J Surg Pathol. 2016;40(12):e94\u2013e102. https:\/\/doi.org\/10.1097\/PAS.0000000000000749.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"8337_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361\u201387. https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.","journal-title":"Stat Med"},{"issue":"13","key":"8337_CR23","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/sim.1802","volume":"23","author":"MJ Pencina","year":"2004","unstructured":"Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23(13):2109\u201323. https:\/\/doi.org\/10.1002\/sim.1802.","journal-title":"Stat Med"},{"issue":"9","key":"8337_CR24","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1097\/01.CCM.0000275267.64078.B0","volume":"35","author":"AA Kramer","year":"2007","unstructured":"Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35(9):2052\u20136. https:\/\/doi.org\/10.1097\/01.CCM.0000275267.64078.B0.","journal-title":"Crit Care Med"},{"issue":"6","key":"8337_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med decision Mak. 2006;26(6):565\u201374. https:\/\/doi.org\/10.1177\/0272989X06295361.","journal-title":"Med decision Mak"},{"issue":"5","key":"8337_CR26","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4318\/tjg.2012.0370","volume":"23","author":"C Jia","year":"2012","unstructured":"Jia C, Zhang Y, Xu J, Sun K. Experience in primary hepatic neuroendocrine tumor. The Turkish J Gastroenterol. 2012;23(5):546\u201351. https:\/\/doi.org\/10.4318\/tjg.2012.0370.","journal-title":"The Turkish J Gastroenterol"},{"issue":"12","key":"8337_CR27","first-page":"1956","volume":"107","author":"H Hasegawa","year":"2010","unstructured":"Hasegawa H, Kuzushita N, Nakazuru S, Itoh M, Araki M, Yoshioka C, et al. Case of primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 2010;107(12):1956\u201362.","journal-title":"Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology"},{"issue":"2","key":"8337_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.beem.2004.11.016","volume":"19","author":"K Oberg","year":"2005","unstructured":"Oberg K, Eriksson B. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours. Best Pract Res Clin Endocrinol Metab. 2005;19(2):265\u201376. https:\/\/doi.org\/10.1016\/j.beem.2004.11.016.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"8337_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cpet.2013.08.007","volume":"9","author":"V Ambrosini","year":"2014","unstructured":"Ambrosini V, Fanti S. 68Ga-DOTA-peptides in the diagnosis of NET. PET Clin. 2014;9(1):37\u201342. https:\/\/doi.org\/10.1016\/j.cpet.2013.08.007.","journal-title":"PET Clin"},{"issue":"2","key":"8337_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1148\/radiology.220.2.r01au25373","volume":"220","author":"S Hoegerle","year":"2001","unstructured":"Hoegerle S, Altehoefer C, Ghanem N, Koehler G, Waller CF, Scheruebl H, et al. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology. 2001;220(2):373\u201380. https:\/\/doi.org\/10.1148\/radiology.220.2.r01au25373.","journal-title":"Radiology"},{"issue":"6","key":"8337_CR31","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1210\/jc.2004-1938","volume":"90","author":"H Orlefors","year":"2005","unstructured":"Orlefors H, Sundin A, Garske U, Juhlin C, Oberg K, Skogseid B, et al. Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab. 2005;90(6):3392\u2013400. https:\/\/doi.org\/10.1210\/jc.2004-1938.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"8337_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/qjmed\/91.4.295","volume":"91","author":"W Shi","year":"1998","unstructured":"Shi W, Johnston CF, Buchanan KD, Ferguson WR, Laird JD, Crothers JG, et al. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging. QJM : monthly journal of the Association of Physicians. 1998;91(4):295\u2013301. https:\/\/doi.org\/10.1093\/qjmed\/91.4.295.","journal-title":"QJM : monthly journal of the Association of Physicians"},{"issue":"10","key":"8337_CR33","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/jamaoncol.2017.0575","volume":"3","author":"PL Kunz","year":"2017","unstructured":"Kunz PL. Understanding neuroendocrine tumors\u2014a NET gain. JAMA Oncol. 2017;3(10):1343\u20134. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0575.","journal-title":"JAMA Oncol"},{"issue":"5","key":"8337_CR34","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1159\/000167021","volume":"25","author":"G Gravante","year":"2008","unstructured":"Gravante G, De Liguori CN, Overton J, Manzia TM, Orlando G. Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments. Dig Surg. 2008;25(5):364\u20138. https:\/\/doi.org\/10.1159\/000167021.","journal-title":"Dig Surg"},{"issue":"3","key":"8337_CR35","first-page":"198","volume":"84","author":"N Mrabet","year":"2006","unstructured":"Mrabet N, Houissa H, Bellil K, Bellil S, Mekni A, Haouet S, et al. Primary hepatic carcinoid tumor: a case report. La Tunisie medicale. 2006;84(3):198\u2013200.","journal-title":"La Tunisie medicale"},{"issue":"4","key":"8337_CR36","first-page":"386","volume":"86","author":"S Jarboui","year":"2008","unstructured":"Jarboui S, Jerraya H, Moussi A, Daldoul S, Morched Abdesselem M, Zaouche A. Primary carcinoid hepatic tumour: a case report. La Tunisie medicale. 2008;86(4):386\u20138.","journal-title":"La Tunisie medicale"},{"issue":"5","key":"8337_CR37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4132\/KoreanJPathol.2012.46.5.443","volume":"46","author":"ES Jung","year":"2012","unstructured":"Jung ES, Kang YK, Cho MY, Kim JM, Lee WA, Lee HE, et al. Update on the proposal for creating a guideline for cancer registration of the gastrointestinal tumors (I-2). Korean J Pathol. 2012;46(5):443\u201353. https:\/\/doi.org\/10.4132\/KoreanJPathol.2012.46.5.443.","journal-title":"Korean J Pathol"},{"issue":"6","key":"8337_CR38","doi-asserted-by":"publisher","first-page":"509","DOI":"10.5152\/tjg.2016.16391","volume":"27","author":"E \u00d6zaslan","year":"2016","unstructured":"\u00d6zaslan E, Bayram F, Karaca H, G\u00fcrsoy \u015e, \u00d6zt\u00fcrk F, S\u00f6z\u00fcer E, et al. Best prognostic factor of neuroendocrine tumors: grade or stage? A multidisciplinary single-center study. Turkish J Gastroenterol. 2016;27(6):509\u201314. https:\/\/doi.org\/10.5152\/tjg.2016.16391.","journal-title":"Turkish J Gastroenterol"},{"key":"8337_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.anndiagpath.2017.04.005","volume":"29","author":"JY Kim","year":"2017","unstructured":"Kim JY, Hong SM, Ro JY. Recent updates on grading and classification of neuroendocrine tumors. Ann Diagn Pathol. 2017;29:11\u20136. https:\/\/doi.org\/10.1016\/j.anndiagpath.2017.04.005.","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"8337_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.anndiagpath.2005.04.013","volume":"10","author":"R Dala","year":"2006","unstructured":"Dala R, Shoosmith J, Lilenbaum R, Cabello-Inchausti B. Primary hepatic neuroendocrine carcinoma: an underdiagnosed entity. Ann Diagn Pathol. 2006;10(1):28\u201331. https:\/\/doi.org\/10.1016\/j.anndiagpath.2005.04.013.","journal-title":"Ann Diagn Pathol"},{"issue":"12","key":"8337_CR41","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1440-1827.2006.02044.x","volume":"56","author":"E Yasuda","year":"2006","unstructured":"Yasuda E, Takeshita A, Murata S, Ihaku Y, Nitta T, Akutagawa H, et al. Neuroendocrine carcinoma of the liver associated with dermatomyositis: autopsy case and review of the literature. Pathol Int. 2006;56(12):749\u201354. https:\/\/doi.org\/10.1111\/j.1440-1827.2006.02044.x.","journal-title":"Pathol Int"},{"issue":"5","key":"8337_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4021\/wjon341w","volume":"2","author":"B Quartey","year":"2011","unstructured":"Quartey B. Primary hepatic neuroendocrine tumor: what do we know now? World J Oncol. 2011;2(5):209\u201316. https:\/\/doi.org\/10.4021\/wjon341w.","journal-title":"World J Oncol"},{"issue":"5","key":"8337_CR43","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/1097-0142(19900301)65:5<1211::AID-CNCR2820650530>3.0.CO;2-M","volume":"65","author":"S Andreola","year":"1990","unstructured":"Andreola S, Lombardi L, Audisio RA, Mazzaferro V, Koukouras D, Doci R, et al. A clinicopathologic study of primary hepatic carcinoid tumors. Cancer. 1990;65(5):1211\u20138. https:\/\/doi.org\/10.1002\/1097-0142(19900301)65:5<1211::AID-CNCR2820650530>3.0.CO;2-M.","journal-title":"Cancer"},{"issue":"3","key":"8337_CR44","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/(SICI)1096-9098(199607)62:3<218::AID-JSO13>3.0.CO;2-2","volume":"62","author":"SC Krishnamurthy","year":"1996","unstructured":"Krishnamurthy SC, Dutta V, Pai SA, Kane SV, Jagannath P, Desouza LJ, et al. Primary carcinoid tumor of the liver: report of four resected cases including one with gastrin production. J Surg Oncol. 1996;62(3):218\u201321. https:\/\/doi.org\/10.1002\/(SICI)1096-9098(199607)62:3<218::AID-JSO13>3.0.CO;2-2.","journal-title":"J Surg Oncol"},{"issue":"10","key":"8337_CR45","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1245\/ASO.2003.10.906","volume":"10","author":"JC Yao","year":"2003","unstructured":"Yao JC, Vauthey JN. Primary and metastatic hepatic carcinoid: is there an algorithm? Ann Surg Oncol. 2003;10(10):1133\u20135. https:\/\/doi.org\/10.1245\/ASO.2003.10.906.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"8337_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1046\/j.1445-2197.2002.02507.x","volume":"72","author":"M Rohaizak","year":"2002","unstructured":"Rohaizak M, Farndon JR. Use of octreotide and lanreotide in the treatment of symptomatic non-resectable carcinoid tumours. ANZ J Surg. 2002;72(9):635\u20138. https:\/\/doi.org\/10.1046\/j.1445-2197.2002.02507.x.","journal-title":"ANZ J Surg"},{"issue":"4","key":"8337_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00000658-199704000-00003","volume":"225","author":"YP Le Treut","year":"1997","unstructured":"Le Treut YP, Delpero JR, Dousset B, Cherqui D, Segol P, Mantion G, et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg. 1997;225(4):355\u201364. https:\/\/doi.org\/10.1097\/00000658-199704000-00003.","journal-title":"Ann Surg"},{"issue":"10","key":"8337_CR48","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/00007890-199811270-00007","volume":"66","author":"T Lehnert","year":"1998","unstructured":"Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation. 1998;66(10):1307\u201312. https:\/\/doi.org\/10.1097\/00007890-199811270-00007.","journal-title":"Transplantation"},{"issue":"4","key":"8337_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-0038-1669936","volume":"38","author":"C Lim","year":"2018","unstructured":"Lim C, Lahat E, Osseis M, Sotirov D, Salloum C, Azoulay D. Liver transplantation for neuroendocrine tumors: what have we learned? Semin Liver Dis. 2018;38(4):351\u20136. https:\/\/doi.org\/10.1055\/s-0038-1669936.","journal-title":"Semin Liver Dis"},{"issue":"31","key":"8337_CR50","doi-asserted-by":"publisher","first-page":"e11764","DOI":"10.1097\/MD.0000000000011764","volume":"97","author":"C Shi","year":"2018","unstructured":"Shi C, Zhao Q, Dai B, Xie F, Yang J. Primary hepatic neuroendocrine neoplasm: long-time surgical outcome and prognosis. Medicine. 2018;97(31):e11764. https:\/\/doi.org\/10.1097\/MD.0000000000011764.","journal-title":"Medicine"},{"issue":"12","key":"8337_CR51","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","volume":"3","author":"DJ Boffa","year":"2017","unstructured":"Boffa DJ, Rosen JE, Mallin K, Loomis A, Gay G, Palis B, et al. Using the National Cancer Database for outcomes research: a review. JAMA Oncol. 2017;3(12):1722\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6905.","journal-title":"JAMA Oncol"},{"key":"8337_CR52","doi-asserted-by":"publisher","first-page":"7931975","DOI":"10.1155\/2017\/7931975","volume":"2017","author":"ME Ibrahim","year":"2017","unstructured":"Ibrahim ME, Abadeer K, Zhai Q, Nassar A. Primary hepatic neuroendocrine tumor with unusual thyroid follicular-like morphologic characteristics. Case Reports Pathol. 2017;2017:7931975.","journal-title":"Case Reports Pathol"},{"issue":"6","key":"8337_CR53","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3892\/mco.2016.822","volume":"4","author":"A Morishita","year":"2016","unstructured":"Morishita A, Yoneyama H, Nomura T, Sakamoto T, Fujita K, Tani J, et al. Primary hepatic neuroendocrine tumor: a case report. Mol Clin Oncol. 2016;4(6):954\u20136. https:\/\/doi.org\/10.3892\/mco.2016.822.","journal-title":"Mol Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08337-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T04:17:16Z","timestamp":1621311436000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08337-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8337"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08337-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"21 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SEER program is publicly accessible, which merely contains anonymous patient information. This study was exempt from the ethical review or the patients\u2019 consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree on the submission of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Each author certifies that he or she has no conflict of interest related to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"567"}}